SCHEMBL14070555

SCHEMBL14070555

CCc1ccc2cc(COC(C)=O)ccc2c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.53
ALDH1A1 P00352 2/20 0.52
CYP1A2 P05177 2/20 0.50
CYP2A6 P11509 1/20 0.50
CA2 P00918 1/20 0.50
AKR1C3 P42330 2/20 0.49
AKR1C2 P52895 2/20 0.49
KDM4E B2RXH2 1/20 0.41
NPC1 O15118 1/20 0.41
LMNA P02545 1/20 0.41
TP53 P04637 1/20 0.41
MAPT P10636 1/20 0.41
MAOA P21397 1/20 0.41
SLC6A2 P23975 1/20 0.41
RAB9A P51151 1/20 0.41
SLC6A3 Q01959 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
PTGS1 P23219 1/20 0.40
HDAC3 O15379 1/20 0.40
HDAC4 P56524 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4186791 0.93 CYP3A4 (0.59) CYP3A4ALDH1A1CYP1A2CA2AKR1C3
SCHEMBL11320167 0.89 CYP3A4 (0.56) CYP3A4ALDH1A1CYP1A2CA2AKR1C3
SCHEMBL10996267 0.86 CYP3A4 (0.53) CYP3A4ALDH1A1CYP1A2CA2AKR1C3
SCHEMBL487508 0.86 ALDH1A1 (0.61) CYP3A4ALDH1A1CYP1A2CYP2A6CA2
SCHEMBL16154053 0.84 ALDH1A1 (0.63) CYP3A4ALDH1A1KDM4ESLC6A2RAB9A
SCHEMBL10017478 0.83 ALDH1A1 (0.67) CYP3A4ALDH1A1CA2LMNAMAPT
SCHEMBL10989390 0.82 PTPN11 (0.49) CYP3A4ALDH1A1CA2KDM4ENPC1
SCHEMBL6338247 0.81 CYP3A4 (0.49) CYP3A4ALDH1A1CYP1A2CA2AKR1C3
SCHEMBL9762060 0.81 GRIN2D (0.52) CYP3A4ALDH1A1CA2KDM4ENPC1
SCHEMBL10017469 0.79 ALDH1A1 (0.55) CYP3A4ALDH1A1CA2LMNASLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080221289-A1 Compounds Comprising 2,6-Naphthyl Groups BASF AKTIENGESELLSCHAFT (DE) 2008-09-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080221289-A1 Compounds Comprising 2,6-Naphthyl Groups SCO2, MT-CO1, CBR1 CYP3A4 447/4885ALDH1A1 1451/4885CYP1A2 290/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.